24 HRS URINE MICRO ALBUMIN at Dr. Essa Lab

24 HRS URINE MICRO ALBUMIN at Dr. Essa Lab

The 24 HRS URINE MICRO ALBUMIN test at Dr. Essa Lab is a highly specialized, non-invasive diagnostic laboratory investigation designed to measure the precise amount of albumin excreted in the urine over a complete 24-hour cycle. Albumin is a vital plasma protein synthesized by the liver that plays a critical role in maintaining oncotic pressure and transporting hormones, vitamins, and drugs throughout the circulatory system. In a healthy physiological state, the kidneys’ glomerular filtration barrier—composed of fenestrated endothelial cells, the glomerular basement membrane, and podocyte slit diaphragms—prevents large molecules like albumin (approximately 66 kilodaltons) from passing into the urinary space. Only a negligible amount of protein is normally excreted.

However, when early structural or functional damage occurs within the renal glomeruli, the integrity of this filtration barrier is compromised. This allows microscopic amounts of albumin to leak into the urine, a clinical state known as microalbuminuria. The 24 HRS URINE MICRO ALBUMIN test is exceptionally sensitive, detecting minute concentrations of albumin that are entirely invisible on standard dipstick urinalysis. At Dr. Essa Lab, this test is performed using advanced immunoturbidimetric assays on fully automated clinical chemistry analyzers, ensuring unmatched diagnostic accuracy, reproducibility, and clinical utility for patients across Karachi and wider Pakistan.

The clinical importance of this investigation lies in its role as an early warning system. It serves as the gold standard for detecting incipient diabetic nephropathy, hypertensive renal damage, and generalized vascular endothelial dysfunction. By identifying renal impairment at the microalbuminuria stage (30 to 300 mg/24 hours), healthcare providers can implement aggressive therapeutic interventions, such as tight glycemic control, blood pressure optimization with renin-angiotensin-aldosterone system (RAAS) blockers, and lifestyle modifications. These interventions can halt, or even reverse, the progression of chronic kidney disease (CKD) toward end-stage renal disease (ESRD).

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the clinical validity of the 24 HRS URINE MICRO ALBUMIN test, as several physiological factors can temporarily elevate urinary albumin excretion, leading to false-positive results. Patients must strictly adhere to the following preparation guidelines:

• Avoid Strenuous Exercise: Refrain from high-intensity physical activity, heavy lifting, or vigorous workouts for at least 24 hours prior to and during the collection period, as physical exertion can induce transient, non-pathological microalbuminuria.
• Hydration Guidelines: Maintain normal fluid intake. Do not severely restrict fluids, but avoid excessive overhydration, which can excessively dilute the specimen.
• Infection and Illness: Delay the test if you are currently experiencing an acute illness, high fever, or a urinary tract infection (UTI), as these conditions temporarily alter glomerular permeability.
• Medication Review: Inform your prescribing physician and the laboratory staff at Dr. Essa Lab of all prescription medications, over-the-counter drugs, and herbal supplements you are taking, particularly anti-hypertensives, diuretics, and NSAIDs.
• Menstruation: Female patients should avoid collecting urine during their menstrual period, as contamination with blood will invalidate the test results.
• Obtain the Correct Container: Visit your nearest Dr. Essa Lab collection center to obtain the designated, clean 24-hour urine collection container. Do not use household containers, as they may contain chemical residues that interfere with the assay.

During the Procedure

The 24-hour urine collection process requires meticulous attention to timing and technique. Every drop of urine produced during the designated 24-hour window must be collected to ensure an accurate quantitative analysis. The step-by-step process is as follows:

• Day 1 – Start the Collection: Upon waking on the first morning (e.g., at 8:00 AM), urinate directly into the toilet. Do not collect this first void. Record this exact time as the start of your 24-hour collection period.
• Collect All Subsequent Voids: For the next 24 hours, collect every single drop of urine you pass into the clean container provided by Dr. Essa Lab. This includes all daytime voids, nighttime voids, and any bowel movement-associated urination.
• Day 2 – Final Collection: Exactly 24 hours after your start time on the second morning (e.g., at 8:00 AM), urinate one final time and add this complete void to the collection container. This marks the end of the collection process.
• Storage Conditions: Throughout the entire 24-hour collection period, the container must be kept cold. Store it in a refrigerator or in a cooler filled with ice packs. Avoid freezing the sample. Keeping the specimen cold prevents bacterial proliferation and preserves protein stability.
• Labeling and Transport: Ensure the container is tightly sealed and clearly labeled with your full name, registration number, and the exact start and end times of the collection. Deliver the container to the nearest Dr. Essa Lab diagnostic center immediately after the final collection.

When is a 24 HRS URINE MICRO ALBUMIN Performed?

Diabetic Nephropathy Screening

Physicians routinely request a 24 HRS URINE MICRO ALBUMIN test for patients diagnosed with diabetes mellitus. In Type 1 diabetes, annual screening typically begins five years post-diagnosis, whereas in Type 2 diabetes, screening commences immediately upon diagnosis and continues annually. Chronic hyperglycemia leads to the formation of advanced glycation end-products (AGEs) and increased oxidative stress, which damages the glomerular basement membrane. The test assists in diagnosing diabetic nephropathy at its earliest, most treatable stage, preventing progression to irreversible renal failure.

Hypertension-Induced Renal Damage

Chronic arterial hypertension exerts high physical pressure on the delicate capillary network of the renal glomeruli, leading to arteriolosclerosis and glomerular hyperfiltration. Over time, this mechanical stress disrupts the filtration barrier, causing albumin to leak into the urine. Physicians order this test for hypertensive patients to assess target organ damage. Detecting microalbuminuria in these patients indicates that high blood pressure is actively damaging the kidneys, prompting immediate pharmacological adjustments to protect the renal vasculature.

Monitoring Existing Chronic Kidney Disease

For patients already diagnosed with early-stage chronic kidney disease, the 24 HRS URINE MICRO ALBUMIN test is performed periodically to monitor the rate of disease progression and evaluate therapeutic efficacy. A stable or declining level of urinary albumin indicates that current medical management—such as blood pressure control, dietary protein restriction, and glycemic management—is successfully protecting remaining nephron function, while rising levels signal the need for therapeutic escalation.

Cardiovascular Risk Assessment

Microalbuminuria is not merely a marker of localized renal impairment; it is a highly sensitive indicator of generalized, systemic endothelial dysfunction. When the endothelial lining of the glomerular capillaries leaks protein, it reflects similar pathological changes occurring within the coronary, cerebral, and peripheral arteries. Physicians utilize this test to stratify cardiovascular risk in patients with metabolic syndrome, dyslipidemia, or a strong family history of cardiovascular events, guiding preventative cardiac care.

Unexplained Swelling or Edema

When patients present with unexplained peripheral edema, particularly localized around the ankles, feet, or periorbital regions, physicians may request a 24 HRS URINE MICRO ALBUMIN test. Significant renal protein loss reduces systemic oncotic pressure, causing fluid to shift from the intravascular space into the interstitial tissues. This test helps differentiate early-stage renal protein loss from other potential etiologies of edema, such as congestive heart failure, hepatic cirrhosis, or localized venous insufficiency.

What Does a 24 HRS URINE MICRO ALBUMIN Detect?

The 24 HRS URINE MICRO ALBUMIN test is a highly sensitive diagnostic tool that detects a wide spectrum of renal, systemic, and physiological conditions, including:

• Incipient Diabetic Nephropathy: Early-stage kidney damage caused by chronic hyperglycemia in diabetic patients.
• Hypertensive Nephrosclerosis: Damage to the renal blood vessels and glomeruli resulting from poorly controlled arterial hypertension.
• Glomerular Endothelial Dysfunction: Systemic loss of endothelial integrity, indicating generalized vascular disease.
• Incipient Renal Impairment: Early-stage decline in overall kidney filtration capacity before serum creatinine rises.
• Preeclampsia: A serious pregnancy complication characterized by high blood pressure and protein leakage, requiring close monitoring.
• Exercise-Induced Albuminuria: Transient, benign elevation of urinary albumin following intense physical exertion.
• Orthostatic Proteinuria: A benign condition where protein is excreted primarily when the patient is upright, returning to normal when lying down.
• Urinary Tract Infections (UTIs): Localized inflammation that can cause temporary, non-pathological leakage of albumin into the urine.
• High Fever-Induced Albuminuria: Temporary alteration of glomerular permeability due to systemic febrile illness.
• Congestive Heart Failure (CHF): Renal venous congestion and altered hemodynamics leading to increased protein excretion.
• Lupus Nephritis: Early renal involvement and glomerular inflammation in patients with Systemic Lupus Erythematosus (SLE).
• Renal Amyloidosis: Deposition of abnormal amyloid proteins in the glomeruli, disrupting the filtration barrier.
• IgA Nephropathy: An autoimmune kidney disease characterized by immunoglobulin A deposition in the glomeruli.
• Membranous Nephropathy: An autoimmune condition causing thickening of the glomerular basement membrane and significant protein leakage.
• Minimal Change Disease: A glomerular disease characterized by the effacement of podocyte foot processes, detectable in its early stages.
• Drug-Induced Nephrotoxicity: Early renal damage caused by therapeutic agents, including NSAIDs, heavy metals, or certain chemotherapeutics.
• Renal Artery Stenosis: Ischemic changes in the kidney due to narrowed renal arteries, leading to hyperfiltration and albuminuria.
• Chronic Interstitial Nephritis: Inflammation of the interstitial spaces of the kidney affecting tubular and glomerular function.
• Alport Syndrome: Early manifestations of genetic basement membrane abnormalities affecting renal filtration.
• Polycystic Kidney Disease (PKD): Early glomerular stress and damage associated with expanding renal cysts.
• Hyperuricemia-Induced Renal Injury: Glomerular damage secondary to chronic high uric acid levels.
• Sickle Cell Nephropathy: Glomerular hyperfiltration and microvascular damage in patients with sickle cell disease.
• Vasculitis: Systemic blood vessel inflammation affecting the renal microvasculature.
• Early Renal Transplant Rejection: Incipient immunological damage to a transplanted kidney, characterized by rising protein levels.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The 24 HRS URINE MICRO ALBUMIN test is processed using state-of-the-art automated systems, allowing us to deliver highly accurate results promptly. Typically, reports are verified by our consultant pathologists and made available within 24 to 48 hours of sample submission.

Patients can easily access their diagnostic reports online through the official Dr. Essa Lab website or dedicated mobile application. By entering their unique patient registration number and password provided on the receipt, patients and their referring physicians can view, download, and print high-resolution PDF reports. Additionally, SMS notifications are sent to patients as soon as their reports are finalized, ensuring seamless and convenient access to critical health data.

24 HRS URINE MICRO ALBUMIN Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
24-Hour Urine Volume	800 to 2,000 mL per 24 hours	Oliguria (<400 mL) or Polyuria (>2,500 mL) indicating collection errors or renal dysfunction.
Microalbumin Concentration	Less than 30 mg per 24 hours	30 to 300 mg per 24 hours, indicating microalbuminuria (early renal damage).
Macroalbumin / Clinical Proteinuria	Negative (not detected in macro quantities)	Greater than 300 mg per 24 hours, indicating established, overt nephropathy.
Urine Creatinine (24-Hour)	0.5 to 2.15 g per 24 hours (varies by muscle mass)	Decreased levels indicating severe renal impairment or incomplete urine collection.
Albumin-to-Creatinine Ratio (ACR)	Less than 30 mg/g of creatinine	30 to 300 mg/g (moderate increase) or >300 mg/g (severe increase).
Urine pH	4.6 to 8.0 (typically slightly acidic)	Abnormal pH values indicating metabolic acidosis, alkalosis, or renal tubular acidosis.
Specific Gravity	1.003 to 1.030	Fixed at 1.010 (isosthenuria), indicating loss of the kidney’s concentrating ability.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for 24 HRS URINE MICRO ALBUMIN?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified, board-certified Consultant Pathologists, Biochemists, and experienced technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication, ensuring a supportive environment throughout the diagnostic process.
• Quality Diagnostic Services: Dr. Essa Lab adheres to strict international quality standards and participates in rigorous external quality assurance programs.
• Professional Reporting: Our reports are highly detailed, clinically structured, and verified by senior medical specialists to ensure absolute accuracy.
• Modern Diagnostic Approach: We utilize advanced, fully automated immunoturbidimetric analyzers and cutting-edge laboratory technology for precise protein quantification.
• Comfortable Environment: Our diagnostic centers across Pakistan are designed to provide a clean, hygienic, and welcoming experience for all patients.
• Convenient Location: With an extensive network of collection points throughout Karachi and other major cities, accessing our services is highly convenient.
• Commitment to Accurate Diagnosis: Since 1987, Dr. Essa Lab has maintained an unwavering commitment to providing accurate, reliable, and affordable diagnostic services to the community.